← Back to Search

Behavioral Intervention

Outreach with patient education and patient navigation services for Hepatocellular Carcinoma

N/A
Waitlist Available
Led By Amit G Singal, MD
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years post randomization
Awards & highlights

Study Summary

This study is evaluating whether a mailed outreach strategy can increase HCC surveillance among patients with cirrhosis.

Eligible Conditions
  • Hepatocellular Carcinoma
  • Liver Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years post randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years post randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Completion of HCC surveillance process
Patient satisfaction and acceptability
Secondary outcome measures
Early HCC
One-time Screening
Repeat Screening

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2: Patient Education and Patient Navigation ServicesExperimental Treatment1 Intervention
Mailed HCC surveillance outreach with patient education and patient navigation services.
Group II: Group 1: Usual CareActive Control1 Intervention
Usual care with opportunistic visit-based HCC surveillance.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Outreach with patient education and patient navigation services
2018
N/A
~2880

Find a Location

Who is running the clinical trial?

Parkland Health and Hospital SystemOTHER
19 Previous Clinical Trials
96,404 Total Patients Enrolled
Michael E. DeBakey VA Medical CenterFED
64 Previous Clinical Trials
12,917 Total Patients Enrolled
University of Texas Southwestern Medical CenterLead Sponsor
1,047 Previous Clinical Trials
1,050,928 Total Patients Enrolled
9 Trials studying Hepatocellular Carcinoma
975 Patients Enrolled for Hepatocellular Carcinoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Clinical Gastroenterology and HepatologyJournal
Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance
Singal, Amit G., Sarah Reddy, Himani Radadiya aka Patel, Deyaun Villarreal, Aisha Khan, Yan Liu, Vanessa Cerda, et al.. 2021. “Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance”. Clinical Gastroenterology and Hepatology. Elsevier BV. doi:10.1016/j.cgh.2021.12.014.
Clinical Gastroenterology and HepatologyJournal
Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance
Singal, Amit G., Sarah Reddy, Himani Radadiya aka Patel, Deyaun Villarreal, Aisha Khan, Yan Liu, Vanessa Cerda, et al.. 2021. “Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance”. Clinical Gastroenterology and Hepatology. Elsevier BV. doi:10.1016/j.cgh.2021.12.014.
clinicaltrials.govStudy
Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5
Amit Singal 2018. "Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02582918.
~410 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top